Skip to main content
Friends in high places: Releaf joins the cannabis industry council

Friends in high places: Releaf joins the cannabis industry council

2 min read

Lucy MacKinnon

Friends in high places: Releaf joins the cannabis industry council
Here at Releaf we are delighted to announce that we have joined the ranks of one of the UK's leading membership organisations for the cannabis industry: The Cannabis Industry Council (CIC).

Key takeaways

  1. Releaf joins the Cannabis Industry Council (CIC) with over 100 stakeholders, advocating for change and patient empowerment in the UK's medical cannabis sector through collaborative efforts encompassing charities, clinical groups, and research bodies.
  2. As the UK's sole all-in-one medical cannabis subscription service, Releaf simplifies patient access with an online platform, offering tailored monthly packages, specialist consultations, and a unique cannabis card to mitigate the stigma and challenges around medicinal cannabis.
  3. Aligning with the CIC, Releaf aims to enhance responsible cannabis access, improve patient outcomes, and contribute to the industry's health, environmental, and economic benefits, addressing regulatory and policy challenges for a more inclusive medical cannabis framework.

As the UK's only all-in-one medical cannabis subscription service, we are enthused to be working alongside over 100 other stakeholders within the CIC to advance the medical cannabis industry and empower patients. 

With members representing each link in the entire cannabis supply chain, the CIC unites charities, clinical groups, and research bodies to revolutionise the industry.

Offering participation in working groups, representation within the government, training courses, as well as events attendance and networking, The Cannabis Industry Council acts as a collective voice to campaign for change.

Commenting on the collaboration, our CEO and Founder Mason Soiza said: 

"We are thrilled to be joining The Cannabis Industry Council. By uniting with like-minded organisations, we can collectively drive positive change in the medical cannabis landscape.

Our vision aligns with the CIC's mission to enhance responsible access to cannabis, improve patient outcomes, and contribute to the industry's health, environmental, and economic benefits." 

Mike Morgan-Giles, The Cannabis Industry Council's CEO, mirrored this excitement commenting: 

"We are delighted to welcome Releaf to the Cannabis Industry Council. Their decision to join highlights how the CIC is becoming increasingly recognised across the sector.

"The medical cannabis sector faces a range of regulatory and policy challenges, and we look forward to Releaf contributing to developing solutions in the interests of the sector."

Here at Releaf, we are passionate about removing the stigma that surrounds medical cannabis in the UK and are dedicated to maintaining a seamless service for our patients by providing their prescribed medications with clarity and compassion.

Our innovative approach allows patients to utilise our comprehensive online platform to simplify the process, offering a convenient and secure way to acquire, consume, and benefit from medicinal cannabis. Accessing medical cannabis can be challenging due to the stigma surrounding it. However, Releaf makes it simple with our tailored monthly packages, specialist consultations for medical cannabis, and a unique medical cannabis card for protection, all based on a patients cannabis prescription.

It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.

Elevate your wellness with medical cannabis

Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.

Am I eligible?

Further reading

The treatment option 1.77 million Brits source illegally: UK’s legal medical cannabis access gap explained

A recent paper clearly highlights the huge gap between how many adults in the UK rely on illicit cannabis to help control the symptoms of their health conditions, compared to the numberlegally prescribed. An estimated 1.77 million UK adults still self-medicate with street-bought cannabis, with only around 100,000 having a legal UK medical cannabis prescription right now, despite medical cannabis being a fully legal treatment option since November 2018.

Pride, PTSD, and plant-based approaches

Each year in June, LGBTQ+ Pride events take place around the world. These events offer an opportunity to celebrate the LGBTQ+ community, honour their contributions, and recognise the ongoing struggle for equality. But June also marks PTSD Awareness Month and, as these two important events coincide, it is important to recognise the increased rates of PTSD among LGBTQ+ individuals, understand the reasons behind this, and improve awareness of available treatment options.